Moderna (MRNA) got full approval Monday for its Covid-19 vaccine from the FDA. The stock is trading higher Monday so we need to see if this could alter the direction of the chart in the weeks ahead. Let's check.
More from Stocks
The Ionic Inflation Protection exchange-traded fund, the latest such ETF to hit the market, offers direct exposure to the consumer price index.
The first half of this year has been ugly. But we could have seen what would happen to Netflix, Tesla and Meta...
Buyers of the shares are becoming more aggressive.
These stocks are priced for an industry-wide calamity, but how realistic is that considering their customer base?